Page last updated: 2024-11-03

praziquantel and Chronic Hepatitis C

praziquantel has been researched along with Chronic Hepatitis C in 2 studies

azinox: Russian drug

Research Excerpts

ExcerptRelevanceReference
"To assess whether schistosomiasis coinfection with chronic hepatitis C virus (HCV) influences hepatic fibrosis and pegylated-interferon/ribavirin (PEG-IFN/RIB) therapy response."3.79Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. ( Abdel-Rahman, M; El Raziky, M; El-Akel, W; El-Sayed, M; Elsharkawy, A; Esmat, G; Ghoneim, H; Khattab, H, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Rahman, M1
El-Sayed, M1
El Raziky, M1
Elsharkawy, A1
El-Akel, W1
Ghoneim, H1
Khattab, H1
Esmat, G1
Chuĭkova, KI1

Other Studies

2 other studies available for praziquantel and Chronic Hepatitis C

ArticleYear
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.
    World journal of gastroenterology, 2013, May-07, Volume: 19, Issue:17

    Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Egypt; Fem

2013
[Complex therapy of chronic viral hepatitis, occurring in combination with opisthorchosis].
    Terapevticheskii arkhiv, 2002, Volume: 74, Issue:11

    Topics: Anthelmintics; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interf

2002